Pre header text goes here. Will show on inbox
To view this email as a web page, click here.

 
ADVERTISEMENT
Ad description here
 
COMMUNITY REPORT
 
Small Doses: The news you need to be the best
Pharmacists are busy people, so we're here to help you learn what you need to know in a way that works for you. Here are four recent news stories that we think you need to know about. The Opioid crisis, antibiotic-resistant bacteria, and cost-cutting are all important issues for every pharmacist (or for anyone involved with healthcare).
Read more
 
ADVERTISEMENT
 
POPULAR ON THE WEB
 
New Legislation Aims to Prohibit DIR Fees
Retail pharmacists are optimistic that Medicare direct and indirect remuneration (DIR) fees could end, if new bills proposed in the U.S. Senate and House are passed.
 
How to Deal with an Angry Customer
With rises in co-pays and issues with denied prescriptions more pharmacists are seeing angry customers. What can they do?
 
Food, Juice, and Drugs: Hold the Grapefruit
Many drugs are known to have interactions with foods and beverages. But are patients educated well enough about these interactions?
 
EDITOR'S CHOICE
 
New CDC Study Finds Shocking Rates of Overdose Deaths
New results from 2015 show that drug overdoses will only keep increasing.
Read more
 
INSIDE THE LATEST ISSUE
 
The Top Six Ways Trump's Policies Will Impact Pharmacies
image description here We're still within the first 100 days of a new administration. What is happening, and what can you expect?

 
CONTINUING EDUCATION
 
Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve
New Options When Statins Are Not Enough
Key cogs in the management of Parkinson's disease
 
DIGITAL EDITION
 
January 2017 | Vol. 161 No. 1
In this issue, we take an in-depth look at Dementia and Alzheimer's, and give you the tools you need to help patients with mental health problems.

Read the whole issue here
 
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.